MersV1, PubMed, Corpus, bibRecord, 000B58

Impact of Comorbidity on Fatality Rate of Patients with Middle East Respiratory Syndrome.

Identifieur interne : 000B58 ( PubMed/Corpus ); précédent : 000B57; suivant : 000B59

Impact of Comorbidity on Fatality Rate of Patients with Middle East Respiratory Syndrome.

Auteurs : Ya-Min Yang ; Chen-Yang Hsu ; Chao-Chih Lai ; Ming-Fang Yen ; Paul S. Wikramaratna ; Hsiu-Hsi Chen ; Tsung-Hsi Wang

Source :

Scientific reports [ 2045-2322 ] ; 2017.

RBID : pubmed:28900101

English descriptors

KwdEn :
- Adult, Aged, Comorbidity, Coronavirus Infections (epidemiology), Coronavirus Infections (mortality), Coronavirus Infections (virology), Female, Humans, Male, Middle Aged, Middle East Respiratory Syndrome Coronavirus, Mortality, Population Surveillance, Risk Factors.
MESH :
- epidemiology : Coronavirus Infections.
- mortality : Coronavirus Infections.
- virology : Coronavirus Infections.
- Adult, Aged, Comorbidity, Female, Humans, Male, Middle Aged, Middle East Respiratory Syndrome Coronavirus, Mortality, Population Surveillance, Risk Factors.

Abstract

To date, 1841 cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection have been reported worldwide, with 652 deaths. We used a publically available case line list to explore the effect of relevant factors, notably underlying comorbidities, on fatal outcome of Middle East respiratory syndrome (MERS) cases up to the end of October 2016. A Bayesian Weibull proportional hazards regression model was used to assess the effect of comorbidity, age, epidemic period and sex on the fatality rate of MERS cases and its variation across countries. The crude fatality rate of MERS cases was 32.1% (95% credibility interval (CI): 29.9%, 34.3%). Notably, the incremental change of daily death rate was most prominent during the first week since disease onset with an average increase of 13%, but then stabilized in the remaining two weeks when it only increased 3% on average. Neither sex, nor country of infection were found to have a significant impact on fatality rates after taking into account the age and comorbidity status of patients. After adjusting for age, epidemic period, MERS patients with comorbidity had around 4 times the risk for fatal infection than those without (adjusted hazard ratio of 3.74 (95% CI: 2.57, 5.67)).

DOI: 10.1038/s41598-017-10402-1
PubMed: 28900101

Links to Exploration step

pubmed:28900101

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Impact of Comorbidity on Fatality Rate of Patients with Middle East Respiratory Syndrome.</title>
<author><name sortKey="Yang, Ya Min" sort="Yang, Ya Min" uniqKey="Yang Y" first="Ya-Min" last="Yang">Ya-Min Yang</name>
<affiliation><nlm:affiliation>Division of Biostatistics, College of Public Health, National Taiwan University, Taipei, Taiwan.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Hsu, Chen Yang" sort="Hsu, Chen Yang" uniqKey="Hsu C" first="Chen-Yang" last="Hsu">Chen-Yang Hsu</name>
<affiliation><nlm:affiliation>Division of Biostatistics, College of Public Health, National Taiwan University, Taipei, Taiwan.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Lai, Chao Chih" sort="Lai, Chao Chih" uniqKey="Lai C" first="Chao-Chih" last="Lai">Chao-Chih Lai</name>
<affiliation><nlm:affiliation>Emergency Department, Taipei City Hospital, Ren-Ai Branch, Taipei, Taiwan. Chaochin@ms1.hinet.net.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Yen, Ming Fang" sort="Yen, Ming Fang" uniqKey="Yen M" first="Ming-Fang" last="Yen">Ming-Fang Yen</name>
<affiliation><nlm:affiliation>School of Oral Hygiene, College of Oral Medicine, Taipei Medical University, Taipei, Taiwan.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Wikramaratna, Paul S" sort="Wikramaratna, Paul S" uniqKey="Wikramaratna P" first="Paul S" last="Wikramaratna">Paul S. Wikramaratna</name>
<affiliation><nlm:affiliation>Institute of Evolutionary Biology, University of Edinburgh, Edinburgh, United Kingdom.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Chen, Hsiu Hsi" sort="Chen, Hsiu Hsi" uniqKey="Chen H" first="Hsiu-Hsi" last="Chen">Hsiu-Hsi Chen</name>
<affiliation><nlm:affiliation>Division of Biostatistics, College of Public Health, National Taiwan University, Taipei, Taiwan.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Wang, Tsung Hsi" sort="Wang, Tsung Hsi" uniqKey="Wang T" first="Tsung-Hsi" last="Wang">Tsung-Hsi Wang</name>
<affiliation><nlm:affiliation>Ministry of Health and Welfare, Taipei, Taiwan. joyce12wang@gmail.com.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2017">2017</date>
<idno type="RBID">pubmed:28900101</idno>
<idno type="pmid">28900101</idno>
<idno type="doi">10.1038/s41598-017-10402-1</idno>
<idno type="wicri:Area/PubMed/Corpus">000B58</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000B58</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Impact of Comorbidity on Fatality Rate of Patients with Middle East Respiratory Syndrome.</title>
<author><name sortKey="Yang, Ya Min" sort="Yang, Ya Min" uniqKey="Yang Y" first="Ya-Min" last="Yang">Ya-Min Yang</name>
<affiliation><nlm:affiliation>Division of Biostatistics, College of Public Health, National Taiwan University, Taipei, Taiwan.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Hsu, Chen Yang" sort="Hsu, Chen Yang" uniqKey="Hsu C" first="Chen-Yang" last="Hsu">Chen-Yang Hsu</name>
<affiliation><nlm:affiliation>Division of Biostatistics, College of Public Health, National Taiwan University, Taipei, Taiwan.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Lai, Chao Chih" sort="Lai, Chao Chih" uniqKey="Lai C" first="Chao-Chih" last="Lai">Chao-Chih Lai</name>
<affiliation><nlm:affiliation>Emergency Department, Taipei City Hospital, Ren-Ai Branch, Taipei, Taiwan. Chaochin@ms1.hinet.net.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Yen, Ming Fang" sort="Yen, Ming Fang" uniqKey="Yen M" first="Ming-Fang" last="Yen">Ming-Fang Yen</name>
<affiliation><nlm:affiliation>School of Oral Hygiene, College of Oral Medicine, Taipei Medical University, Taipei, Taiwan.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Wikramaratna, Paul S" sort="Wikramaratna, Paul S" uniqKey="Wikramaratna P" first="Paul S" last="Wikramaratna">Paul S. Wikramaratna</name>
<affiliation><nlm:affiliation>Institute of Evolutionary Biology, University of Edinburgh, Edinburgh, United Kingdom.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Chen, Hsiu Hsi" sort="Chen, Hsiu Hsi" uniqKey="Chen H" first="Hsiu-Hsi" last="Chen">Hsiu-Hsi Chen</name>
<affiliation><nlm:affiliation>Division of Biostatistics, College of Public Health, National Taiwan University, Taipei, Taiwan.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Wang, Tsung Hsi" sort="Wang, Tsung Hsi" uniqKey="Wang T" first="Tsung-Hsi" last="Wang">Tsung-Hsi Wang</name>
<affiliation><nlm:affiliation>Ministry of Health and Welfare, Taipei, Taiwan. joyce12wang@gmail.com.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">Scientific reports</title>
<idno type="eISSN">2045-2322</idno>
<imprint><date when="2017" type="published">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Comorbidity</term>
<term>Coronavirus Infections (epidemiology)</term>
<term>Coronavirus Infections (mortality)</term>
<term>Coronavirus Infections (virology)</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Middle East Respiratory Syndrome Coronavirus</term>
<term>Mortality</term>
<term>Population Surveillance</term>
<term>Risk Factors</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Coronavirus Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Coronavirus Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Coronavirus Infections</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Comorbidity</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Middle East Respiratory Syndrome Coronavirus</term>
<term>Mortality</term>
<term>Population Surveillance</term>
<term>Risk Factors</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">To date, 1841 cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection have been reported worldwide, with 652 deaths. We used a publically available case line list to explore the effect of relevant factors, notably underlying comorbidities, on fatal outcome of Middle East respiratory syndrome (MERS) cases up to the end of October 2016. A Bayesian Weibull proportional hazards regression model was used to assess the effect of comorbidity, age, epidemic period and sex on the fatality rate of MERS cases and its variation across countries. The crude fatality rate of MERS cases was 32.1% (95% credibility interval (CI): 29.9%, 34.3%). Notably, the incremental change of daily death rate was most prominent during the first week since disease onset with an average increase of 13%, but then stabilized in the remaining two weeks when it only increased 3% on average. Neither sex, nor country of infection were found to have a significant impact on fatality rates after taking into account the age and comorbidity status of patients. After adjusting for age, epidemic period, MERS patients with comorbidity had around 4 times the risk for fatal infection than those without (adjusted hazard ratio of 3.74 (95% CI: 2.57, 5.67)).</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28900101</PMID>
<DateCompleted><Year>2019</Year>
<Month>06</Month>
<Day>21</Day>
</DateCompleted>
<DateRevised><Year>2019</Year>
<Month>06</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>7</Volume>
<Issue>1</Issue>
<PubDate><Year>2017</Year>
<Month>09</Month>
<Day>12</Day>
</PubDate>
</JournalIssue>
<Title>Scientific reports</Title>
<ISOAbbreviation>Sci Rep</ISOAbbreviation>
</Journal>
<ArticleTitle>Impact of Comorbidity on Fatality Rate of Patients with Middle East Respiratory Syndrome.</ArticleTitle>
<Pagination><MedlinePgn>11307</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-017-10402-1</ELocationID>
<Abstract><AbstractText>To date, 1841 cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection have been reported worldwide, with 652 deaths. We used a publically available case line list to explore the effect of relevant factors, notably underlying comorbidities, on fatal outcome of Middle East respiratory syndrome (MERS) cases up to the end of October 2016. A Bayesian Weibull proportional hazards regression model was used to assess the effect of comorbidity, age, epidemic period and sex on the fatality rate of MERS cases and its variation across countries. The crude fatality rate of MERS cases was 32.1% (95% credibility interval (CI): 29.9%, 34.3%). Notably, the incremental change of daily death rate was most prominent during the first week since disease onset with an average increase of 13%, but then stabilized in the remaining two weeks when it only increased 3% on average. Neither sex, nor country of infection were found to have a significant impact on fatality rates after taking into account the age and comorbidity status of patients. After adjusting for age, epidemic period, MERS patients with comorbidity had around 4 times the risk for fatal infection than those without (adjusted hazard ratio of 3.74 (95% CI: 2.57, 5.67)).</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yang</LastName>
<ForeName>Ya-Min</ForeName>
<Initials>YM</Initials>
<AffiliationInfo><Affiliation>Division of Biostatistics, College of Public Health, National Taiwan University, Taipei, Taiwan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Hsu</LastName>
<ForeName>Chen-Yang</ForeName>
<Initials>CY</Initials>
<AffiliationInfo><Affiliation>Division of Biostatistics, College of Public Health, National Taiwan University, Taipei, Taiwan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Lai</LastName>
<ForeName>Chao-Chih</ForeName>
<Initials>CC</Initials>
<AffiliationInfo><Affiliation>Emergency Department, Taipei City Hospital, Ren-Ai Branch, Taipei, Taiwan. Chaochin@ms1.hinet.net.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Yen</LastName>
<ForeName>Ming-Fang</ForeName>
<Initials>MF</Initials>
<AffiliationInfo><Affiliation>School of Oral Hygiene, College of Oral Medicine, Taipei Medical University, Taipei, Taiwan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Wikramaratna</LastName>
<ForeName>Paul S</ForeName>
<Initials>PS</Initials>
<AffiliationInfo><Affiliation>Institute of Evolutionary Biology, University of Edinburgh, Edinburgh, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Chen</LastName>
<ForeName>Hsiu-Hsi</ForeName>
<Initials>HH</Initials>
<AffiliationInfo><Affiliation>Division of Biostatistics, College of Public Health, National Taiwan University, Taipei, Taiwan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Wang</LastName>
<ForeName>Tsung-Hsi</ForeName>
<Initials>TH</Initials>
<AffiliationInfo><Affiliation>Ministry of Health and Welfare, Taipei, Taiwan. joyce12wang@gmail.com.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>School of Medicine, National Yangming University, Taipei, Taiwan. joyce12wang@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2017</Year>
<Month>09</Month>
<Day>12</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Sci Rep</MedlineTA>
<NlmUniqueID>101563288</NlmUniqueID>
<ISSNLinking>2045-2322</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D065207" MajorTopicYN="Y">Middle East Respiratory Syndrome Coronavirus</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009026" MajorTopicYN="N">Mortality</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011159" MajorTopicYN="N">Population Surveillance</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year>
<Month>04</Month>
<Day>25</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2017</Year>
<Month>08</Month>
<Day>07</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2017</Year>
<Month>9</Month>
<Day>14</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2017</Year>
<Month>9</Month>
<Day>14</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2019</Year>
<Month>6</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">28900101</ArticleId>
<ArticleId IdType="doi">10.1038/s41598-017-10402-1</ArticleId>
<ArticleId IdType="pii">10.1038/s41598-017-10402-1</ArticleId>
<ArticleId IdType="pmc">PMC5596001</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Lancet Infect Dis. 2013 May;13(5):436-48</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23531392</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dev Ctries. 2013 Jun 15;7(6):497-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23771295</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Infect Dis. 2013 Sep;17 (9):e668-72</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23916548</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Epidemiol. 2016 Sep 15;184(6):460-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27608662</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Euro Surveill. 2015 Jun 25;20(25):1-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26132766</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Microbes Infect. 2017 Jun 7;6(6):e51</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28588290</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS Curr. 2014 Dec 18;6:null</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25685622</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mol Syst Biol. 2009;5:262</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19357641</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2012 Nov 8;367 (19):1814-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23075143</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Stat Med. 2002 Aug 15;21(15):2175-97</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12210632</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>MBio. 2014 Feb 18;5(1):null</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24549846</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2013 Jun 29;381(9885):2265-72</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23727167</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2013 Jun 27;368(26):2487-94</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23718156</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMC Bioinformatics. 2014 Oct 24;15:333</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25344230</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virol J. 2016 Jun 03;13:87</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27255185</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Med Mal Infect. 2014 Sep;44(9):412-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25193630</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Epidemiol. 2016 Apr 1;183(7):657-63</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26851269</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2013 Aug 24;382(9893):694-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23831141</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMJ. 2013 May 23;346:f3372</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23704132</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Stat Med. 2000 Dec 30;19(24):3309-24</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11122497</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Euro Surveill. 2013 Sep 26;18(39):null</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24094061</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMC Med. 2015 Sep 30;13:228</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26420593</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2013 Dec 14;382(9909):1993-2002</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24055451</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2013 Jul;87(14):7790-2</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23678167</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2014 Apr;20(4):620-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24655721</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2013 Aug 1;369(5):407-16</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23782161</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2015 Sep 5;386(9997):995-1007</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26049252</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2003 Jun;9(6):718-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12781013</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Epidemiol. 2005 Sep 1;162(5):479-86</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16076827</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Euro Surveill. 2013 Aug 22;18(34):null</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23987829</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Euro Surveill. 2015 Jun 25;20(25):7-13</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26132767</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Infect Dis. 2013 Sep;13(9):752-61</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23891402</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Infect Dis. 2014 Jun;23 :63-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24699184</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Thorax. 2003 Aug;58(8):686-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12885985</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Respir Med. 2015 Jul;3(7):509-10</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26050550</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Infect Dis. 2014 Jan;14 (1):50-56</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24239323</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>MMWR Recomm Rep. 2010 Aug 6;59(RR-8):1-62</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20689501</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/PubMed/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000B58 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000B58 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:28900101
   |texte=   Impact of Comorbidity on Fatality Rate of Patients with Middle East Respiratory Syndrome.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:28900101" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a MersV1

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021

	Serveur d'exploration MERS
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration MERS

Impact of Comorbidity on Fatality Rate of Patients with Middle East Respiratory Syndrome.

Impact of Comorbidity on Fatality Rate of Patients with Middle East Respiratory Syndrome.

Source :

English descriptors

Abstract

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki